Furthermore, re-analysis of a tissue microarray comprising 1,212 samples from a Finnish nationwide population-based breast cancer series (FinProg cohort), previously stained for MYO10 (ref. 13) and pSrcY416 (refs 13, 32), revealed that MYO10 protein levels correlate with Src activity in patient samples (Fig. 6g; Table 1). This evidence concerns the gene MYO10 and breast cancer.